We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAQU
2026
DELISTED
Counter Press Acquisition Corporation Unit
CPAQU
$2.02M ﹤0.01%
+200,000
New +$2.02M
DV icon
2027
DoubleVerify
DV
$1.77B
$2.02M ﹤0.01%
80,063
+27,411
+52% +$713K
PATH icon
2028
UiPath
PATH
$6.52B
$2.01M ﹤0.01%
+93,306
New +$3.14M
TOACW
2029
CALL
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
$2.01M ﹤0.01%
+200,000
New +$72.5K
PLAOU
2030
DELISTED
Patria Latin American Opportunity Acquisition Corp. Unit
PLAOU
$2.01M ﹤0.01%
+200,000
New +$2.01M
LGVCW
2031
CALL
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$2.01M ﹤0.01%
+202,285
New +$74.7K
BFIIW
2032
CALL
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$2M ﹤0.01%
480,000
+30,000
+7% +$20.4K
LFAC
2033
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$2M ﹤0.01%
+200,100
New +$1.99M
IVCB
2034
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$2M ﹤0.01%
+199,998
New +$1.99M
CWEN.A
2035
DELISTED
Clearway Energy Class A
CWEN.A
$1.99M ﹤0.01%
+59,826
New +$1.87M
FAASW
2036
CALL
DELISTED
DigiAsia Corp Warrant
FAASW
$1.99M ﹤0.01%
199,995
AGNC icon
2037
AGNC Investment
AGNC
$12.7B
$1.99M ﹤0.01%
151,795
-56,693
-27% -$793K
AVY icon
2038
Avery Dennison
AVY
$12.8B
$1.99M ﹤0.01%
11,435
-66,300
-85% -$12.3M
LILA icon
2039
Liberty Latin America Class A
LILA
$1.72B
$1.99M ﹤0.01%
301,694
-37,904
-11% -$273K
DNAB
2040
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$1.99M ﹤0.01%
203,981
DPCSW
2041
CALL
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
$1.99M ﹤0.01%
+200,000
New +$81.4K
DCRDW
2042
CALL
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$1.99M ﹤0.01%
199,995
NPABW
2043
CALL
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$1.99M ﹤0.01%
+200,000
New +$99K
OPALW
2044
CALL
DELISTED
OPAL Fuels Inc. Warrant
OPALW
$1.99M ﹤0.01%
200,000
SCUA.WS
2045
CALL
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$1.98M ﹤0.01%
+199,997
New +$80.5K
BMI icon
2046
Badger Meter
BMI
$3.87B
$1.98M ﹤0.01%
+19,879
New +$1.95M
FIACW
2047
CALL
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$1.98M ﹤0.01%
200,000
EQD.WS
2048
CALL
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$1.98M ﹤0.01%
200,000
BRD.WS
2049
CALL
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$1.98M ﹤0.01%
+200,000
New +$75K
PAHC icon
2050
Phibro Animal Health
PAHC
$1.5B
$1.97M ﹤0.01%
+98,999
New +$2M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.